Myriad Genetics, Inc. (MYGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myriad Genetics, Inc. (MYGN)

MYGN 6.480

+3.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew G. who wrote (8)	3/27/1997 9:35:00 PM
From: PSC	of 2355

The fact that Myriad Genetics is charging $2500 for genetic testing for the BRCA1 and BRCA2 genes, itself is equal to the price of a therapeutic. I know from personal experience that people are lining up to get tested for these gene mutations. I thought that Myriad was only looking for diagnostic products, not therapeutic ones. Does anyone know differently?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next